Apple is removing a blood-oxygen sensor from some of its smartwatches to get around a patent dispute related to the technology, a step likely to avoid further sales disruptions but that may raise questions about the company’s push into health. The company halted sales of some watch models briefly last month after a U.S. import ban went into effect stemming from an October ruling by the U.S International Trade Commission. The trade agency found Apple had violated the patents of medical-technology company Masimo related to the blood-oxygen tool. Livemint tops charts as the fastest growing news website in the world 🌏 Click here to know more. From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away!

Source: Wall Street Journal January 16, 2024 07:49 UTC